TRxADE HEALTH, Inc. (MEDS) |
|
6.8067 0.017 (0.25%)
|
09-27 10:22 |
|
Open: |
6.63 |
Pre. Close: |
6.79 |
|
High:
|
6.94 |
Low:
|
6.63 |
|
Volume:
|
2,195 |
Market Cap:
|
8(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 9:47:44 AM |
|
Short-term rate:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 13.18 One year: 16.78 |
| Support: |
Support1: 6.3 Support2: 5.24 |
| Resistance: |
Resistance1: 11.28 Resistance2: 14.36 |
| Pivot: |
8.37  |
| Moving Average: |
MA(5): 6.94 MA(20): 8.66
MA(100): 7.85 MA(250): 7.81 |
| MACD: |
MACD(12,26): -0.5 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 8 %D(3): 7.2 |
| RSI: |
RSI(14): 41.3 |
| 52-week: |
High: 19.7 Low: 3.76 |
| Average Vol(K): |
3-Month: 434 (K) 10-Days: 38 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MEDS ] has closed above bottom band by 28.4%. Bollinger Bands are 16.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.19 - 7.23 |
7.23 - 7.26 |
|
Low:
|
6.51 - 6.57 |
6.57 - 6.61 |
|
Close:
|
6.71 - 6.79 |
6.79 - 6.86 |
|
Company Description |
|
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida. |
Headline News |
Thu, 21 Sep 2023
Is Trxade Health Inc (MEDS) a Stock to Watch After Losing -10.41% This Week? - InvestorsObserver
Thu, 07 Sep 2023
Communication Services Stocks on the Move Thursday: FUBO, BHAT, MEDS, TMUS, GROM, TRKA, SSP, AMCX - InvestorsObserver
Thu, 07 Sep 2023
Superlatus Announces Planned Expansion into Pet Food Market - GlobeNewswire
Tue, 05 Sep 2023
Why NextGen Healthcare Shares Are Trading Higher By 13%; Here ... - Investing.com UK
Tue, 05 Sep 2023
Should You Sell Trxade Health Inc (MEDS) Stock Tuesday Morning? - InvestorsObserver
Fri, 01 Sep 2023
Communication Services Stocks Making Moves Friday: MEDS, FUBO, WWE, ZH, SBGI, NXST, WBD, SSP - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Pharmaceutical Retailers |
| Shares Out. |
0 (M) |
| Shares Float |
1 (M) |
|
% Held by Insiders
|
915930 (%) |
|
% Held by Institutions
|
50.6 (%) |
|
Shares Short
|
5 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-2.26e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
-43.3 |
|
Operating Margin (%)
|
-23.9 |
|
Return on Assets (ttm)
|
-30 |
|
Return on Equity (ttm)
|
-1 |
|
Qtrly Rev. Growth
|
9.43e+006 |
|
Gross Profit (p.s.)
|
-16.48 |
|
Sales Per Share
|
326.58 |
|
EBITDA (p.s.)
|
2.41053e+006 |
|
Qtrly Earnings Growth
|
-5.6 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0.02 |
|
Price to Cash Flow
|
-6.95 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
6170 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
